Insulin-like Growth Factor-I Extends in VitroReplicative Life Span of Skeletal Muscle Satellite Cells by Enhancing G1/S Cell Cycle Progression via the Activation of Phosphatidylinositol 3′-Kinase/Akt Signaling Pathway*
暂无分享,去创建一个
[1] F. Booth,et al. IGF‐I restores satellite cell proliferative potential in immobilized old skeletal muscle , 2000, Journal of applied physiology.
[2] E. Lam,et al. Inhibition of the Phosphoinositide 3-Kinase Pathway Induces a Senescence-like Arrest Mediated by p27Kip1 * , 2000, The Journal of Biological Chemistry.
[3] D. Leroith,et al. Conditional Knockout of Mouse Insulin-Like Growth Factor-1 Gene Using the Cre/loxP System , 2000 .
[4] W. Russell,et al. Reversible G1 Arrest Induced by Inhibition of the Epidermal Growth Factor Receptor Tyrosine Kinase Requires Up-regulation of p27KIP1 Independent of MAPK Activity* , 2000, The Journal of Biological Chemistry.
[5] E. Kandel,et al. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. , 1999, Experimental cell research.
[6] Y. Lau,et al. Effect of insulin‐like growth factor 1 on PHA‐stimulated cord blood mononuclear cell telomerase activity , 1999, British journal of haematology.
[7] Hong Sun,et al. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[8] A. Musarò,et al. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] A. Klippel,et al. Activation of Phosphatidylinositol 3-Kinase Is Sufficient for Cell Cycle Entry and Promotes Cellular Changes Characteristic of Oncogenic Transformation , 1998, Molecular and Cellular Biology.
[10] D. Leroith,et al. Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. , 1998, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[11] G. Adams,et al. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. , 1998, Journal of applied physiology.
[12] C. Harley,et al. Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.
[13] B. van der Burg,et al. Mitogenic Signaling of Insulin-like Growth Factor I in MCF-7 Human Breast Cancer Cells Requires Phosphatidylinositol 3-Kinase and Is Independent of Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.
[14] B. Groner,et al. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. , 1997, Immunity.
[15] S. R. Datta,et al. Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.
[16] G. Butler-Browne,et al. Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. , 1997, Human gene therapy.
[17] P. Nisen,et al. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery. , 1997, The Journal of clinical investigation.
[18] Sam W. Lee,et al. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells , 1997, Oncogene.
[19] P. Tsichlis,et al. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Florini,et al. The Mitogenic and Myogenic Actions of Insulin-like Growth Factors Utilize Distinct Signaling Pathways* , 1997, The Journal of Biological Chemistry.
[21] M. R. Calera,et al. Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways , 1996, Molecular and cellular biology.
[22] J R Florini,et al. Growth hormone and the insulin-like growth factor system in myogenesis. , 1996, Endocrine reviews.
[23] A. Schulze,et al. Copyright � 1996, American Society for Microbiology Anchorage-Dependent Transcription of the Cyclin A Gene , 1996 .
[24] O. Pereira-smith,et al. Replicative Senescence: Implications for in Vivo Aging and Tumor Suppression , 1996, Science.
[25] Nobuyuki Shishido,et al. Mice Lacking p27 Kip1 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors , 1996, Cell.
[26] James M. Roberts,et al. A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 Kip1 -Deficient Mice , 1996, Cell.
[27] K. Manova-Todorova,et al. Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27 Kip1 , 1996, Cell.
[28] K. Riabowol,et al. Differential CDK-inhibitor gene expression in aging human diploid fibroblasts , 1996, Experimental Gerontology.
[29] M. Shuford,et al. Tumor suppression and inhibition of aneuploid cell accumulation in human brain tumor cells by ectopic overexpression of the cyclin-dependent kinase inhibitor p27KIP1. , 1996, The Journal of clinical investigation.
[30] A. Bridges,et al. A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[31] Robert J. Schwartz,et al. Myogenic Vector Expression of Insulin-like Growth Factor I Stimulates Muscle Cell Differentiation and Myofiber Hypertrophy in Transgenic Mice (*) , 1995, The Journal of Biological Chemistry.
[32] James M. Roberts,et al. Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.
[33] E. Lees. Cyclin dependent kinase regulation. , 1995, Current opinion in cell biology.
[34] M. Koegl,et al. The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[35] Tony Hunter,et al. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.
[36] James M. Roberts,et al. Cloning of p27 Kip1 , a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals , 1994, Cell.
[37] K Y Hui,et al. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.
[38] S. Reed,et al. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[39] S. Goldstein,et al. Accumulation of insulin‐like growth factor binding protein‐3 in conditioned medium of human fibroblasts increases with chronologic age of donor and senescence in vitro , 1993, Journal of cellular physiology.
[40] James M. Roberts,et al. Cyclin-dependent regulation of G1 in mammalian fibroblasts. , 1993, Science.
[41] D. Clemmons,et al. The insulin-like growth factors. , 1993, Annual review of physiology.
[42] J. Nevins,et al. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.
[43] K. Matsumoto,et al. Phosphorylation of the retinoblastoma protein by cdk2. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[44] J. Angello. Replicative potential and the duration of the cell cycle in human fibroblasts: Coordinate stimulation by epidermal growth factor , 1992, Mechanisms of Ageing and Development.
[45] Y. Qian,et al. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle , 1991, Cell.
[46] G. Stein,et al. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. , 1990, Science.
[47] A. Pardee. G1 events and regulation of cell proliferation. , 1989, Science.
[48] S. Kaufman,et al. Replicating myoblasts express a muscle-specific phenotype. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[49] V. Cristofalo,et al. Expression of cell cycle-dependent genes in young and senescent WI-38 fibroblasts. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[50] W. Wright. Myoblast senescence in muscular dystrophy. , 1985, Experimental cell research.
[51] D. Fischman,et al. Immunocytochemical analysis of intermediate filaments in embryonic heart cells with monoclonal antibodies to desmin , 1984, The Journal of cell biology.
[52] D. Fischman,et al. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro , 1982, The Journal of cell biology.
[53] O. Pereira-smith,et al. A general method for determining the replicative age of normal animal cell cultures , 1980, Mechanisms of Ageing and Development.
[54] H. Green,et al. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes , 1977, Nature.
[55] L. Hayflick,et al. The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.
[56] F. Stockdale,et al. DNA synthesis and myogenesis. , 1961, Experimental cell research.